Bullish Moving Averages
11
Bearish Moving Averages
5
Back Stocks profile
Stock analysis tool for investors
Performance
Open Price
11.00Prev. Close
9.1100Volume
92000.00Value
1020280.00Fundamentals
Market Cap Cr
27.60
Price to Earnings
0.00
Price to Book Value
1.10
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
0.00
Net Profit TTM Cr
0.00
Cash From Operating Activity Cr
5.32
Return on Equity %
1.79
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
87
Week
87.5
Month
82.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
11.09
PIVOT
First Resistance
11.50
Second Resistance
11.92
Third Resistance
12.33
First Support
10.67
Second Support
10.26
Third Support
9.84
Relative Strength Index
58.95
Money Flow Index
80.36
MACD
0.42
MACD Signal
0.28
Average True Range
0.61
Average Directional Index
24.54
Rate of Change (21)
22.54
Rate of Change (125)
-25.47
Commodity Channel Index
64
Williams %R
-34.8
BETA
1 Month
0.51
3 Month
0.23
1 Year
0.14
3 Year
PRICE CHANGE ANALYSIS
↓ -5.05%
1 Week
Low
High
10.67
12.2
↑ 20.54%
1 Month
Low
High
8.62
12.28
↓ -9.17%
3 Months
Low
High
8.62
12.7
↓ -16.99%
6 Months
Low
High
8.5
19.44
↓ -24.56%
1 Year
Low
High
8.5
19.44
22 Jun 2024
Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 22Nd June, 2024
Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 22nd June, 2024 at the Registered Office of the Company which commenced at 02:00 P.M. and concluded at 02:30 P.M. has considered and approved Allotted 1,13,00,000 (One Crore and Thirteen Lakhs Thousand) fully paid-up Equity shares of face value of Rs. 10.00/- (Rupees Ten Only) per share, at a price of Rs. 17/- (Rupees Seventeen Only) per share, aggregating to Rs. 19,21,00,000/- (Rupees Nineteen Crore Twenty One Lakhs Only) for cash consideration to the person(s)/ entity(ies) belonging to Non-Promoter category on a preferential basis in accordance with provisions of Chapter V of SEBI (ICDR) Regulations, 2018, as mentioned in 'Annexure - I'.
11 Jun 2024
Evoq Remedies Ltd - 543500 - Intimation Of In-Principle Approval Received For Issue And Allotment Upto 1,13,00,000 Equity Shares By Evoq Remedies Limited ('The Company') Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Intimation for In-principle Approval
27 May 2024
Evoq Remedies Ltd - 543500 - Submission Of Audited Financial Results For The Half Year And Year Ended On 31St March, 2024 Along With Auditor'S Report
Submission of Audited Financial results
27 May 2024
Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. On 27Th May, 2024
Pursuant to Regulations 30 (6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., on 27th May, 2024, at the registered Office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380060, which commenced at 04:00 P.M. and concluded at 8:00 P.M., inter alia has considered and approved Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditors report.
20 May 2024
Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 27Th May, 2024
Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company will be held on Monday, 27th May, 2024 at 4:00 P.M. at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380060, to consider and approve the Audited Financial Results of the Company for the Half-year and year ended on 31st March, 2024 along with Auditor's Report.
30 Apr 2024
Evoq Remedies Ltd - 543500 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024
Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the financial year ended on 31st March, 2024
27 Apr 2024
Evoq Remedies Ltd - 543500 - Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024
Submission of certificate under Regulation 40(9) read with Regulation 40(10) of SEBI(LODR) Regulations, 2015.
15 Apr 2024
Evoq Remedies Ltd - 543500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 for the Quarter ended on 31st March, 2024.
11 Apr 2024
Evoq Remedies Ltd - 543500 - Clarification Sought On Significant Movement In Price
Clarification Sought on Significant movement in price.
04 Apr 2024
Evoq Remedies Ltd - 543500 - Clarification sought from Evoq Remedies Ltd
The Exchange has sought clarification from Evoq Remedies Ltd on April 4, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
